Results 61 to 70 of about 3,957 (191)
Abstract Pretreatment prediction of neoadjuvant response remains an unresolved challenge in locally advanced rectal cancer, where management is moving towards risk‐adapted and response‐oriented treatment strategies. Prediction remains difficult because response reflects interacting tumour‐intrinsic, immune, stromal, and spatial processes that are ...
Gina F Boot +17 more
wiley +1 more source
Immunoscoring breast cancer: TILs remember what they target
n ...
G. Curigliano, E. A. Perez
openaire +3 more sources
ABSTRACT With the approval of immunotherapies by regulatory bodies, head and neck squamous cell carcinoma (HNSCC) treatment has been revolutionized, and anti‐programmed cell death‐1 (anti‐PD‐1) agents are now the standard for platinum‐resistant recurrent/metastatic HNSCC.
Xiao‐Tong Yan +2 more
wiley +1 more source
Immunoscore: a new possible approach for melanoma classification [PDF]
Meeting abstracts Increasing evidence has supported the hypothesis that cancer development is influenced by the host immune system. The number, type and location of the immune cells infiltrating the tumor microenvironment (TILs) may either limit or promote tumor progression [[1][1 ...
Capone, Mariaelena +11 more
openaire +1 more source
To reinforce the confidence on the statistical analyses, patients with poor postoperative outcome (I0 and I1) were pooled. The Kaplan–Meier curves illustrate the DFS according to the Immunoscore and show significant differences between patient groups ...
Maria-Gabriela Anitei (14992050) +17 more
core +2 more sources
ABSTRACT Background Oral squamous cell carcinoma (OSCC) is an aggressive malignancy with limited prognostic biomarkers, in which metabolic reprogramming contributes to tumor progression. Amino acid transporters of the solute carrier family have emerged as key regulators of cancer biology; however, the role of solute carrier family 7 member 3 (SLC7A3 ...
Lilianny Querino Rocha de Oliveira +7 more
wiley +1 more source
Application of the Immunoscore as prognostic tool for hepatocellular carcinoma
To date, the American Joint Committee on Cancer (AJCC) and the Union for International Cancer Control (UICC) tumor, nodes, metastasis (TNM) classification represents the standard system for evaluation of prognosis in solid tumors. However, the clinical outcome can be significantly different in patients with the same TNM stage.
Annacarmen Petrizzo, Luigi Buonaguro
openaire +3 more sources
ABSTRACT The interplay between diet, gut microbiota, and host immunity is central to food science. The Lachnospiraceae family ferments dietary fibers to produce short‐chain fatty acids (SCFAs), notably butyrate and propionate, with immunomodulatory potential. This critical review distinguishes established findings from hypotheses.
Ruijun Wang +4 more
wiley +1 more source
Immunoscore predicts significant differences in time to recurrence in stage I colon cancer patients
Immunoscore® is an in vitro diagnostic test that predicts the risk of relapse in patients with Colon Cancer (CC) by measuring the host immune response at the tumor site.
Kawakami, Y. +20 more
core +1 more source
ABSTRACT Objectives Laryngeal cancer incidence has risen globally, yet survival outcomes have shown limited improvement over recent decades. This study evaluated contemporary outcomes across multiple centres in Northern UK and examined stage‐ and treatment‐specific survival. Design Multi‐centre retrospective observational study.
Amar Rajgor +54 more
wiley +1 more source

